Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease ; volume:16 ; number:1 ; day:25 ; month:9 ; year:2024 ; pages:1-11 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (25.9.2024), 1-11, 12.2024
- Urheber
-
Johansson, Charlotte
Thordardottir, Steinunn
Laffita-Mesa, José
Pannee, Josef
Rodriguez-Vieitez, Elena
Zetterberg, Henrik
Blennow, Kaj
Graff, Caroline
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-024-01574-w
- URN
-
urn:nbn:de:101:1-2412112116203.756094821174
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
22.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Johansson, Charlotte
- Thordardottir, Steinunn
- Laffita-Mesa, José
- Pannee, Josef
- Rodriguez-Vieitez, Elena
- Zetterberg, Henrik
- Blennow, Kaj
- Graff, Caroline
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Origins of amyloid-β
Heteromers of amyloid precursor protein in cerebrospinal fluid
Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Origins of amyloid-β
Heteromers of amyloid precursor protein in cerebrospinal fluid
Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study
A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
Decreased levels of soluble amyloid β-protein precursor and β-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Origins of amyloid-β
Heteromers of amyloid precursor protein in cerebrospinal fluid
Performance on a pattern separation task by Alzheimer’s patients shows possible links between disrupted dentate gyrus activity and apolipoprotein E ∈4 status and cerebrospinal fluid amyloid-β42 levels